Medpace Holdings valuation
Valuation
The P/E ratio is 36.3. The average price target of 13 analysts is $651.31.
Data as of November 17, 2026
Medpace Holdings compared with similar companies
Medpace Holdings's P/E (trailing 12 months): 36.3, in line with the median of a group of 9 similar companies (36.3).
| Metric | Medpace Holdings | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 36.3 | 36.3 | 31.5 – 70.5 | Middle |
| Forward P/E | 32.9 | 26.1 | 19.0 – 32.0 | High |
| EV/EBITDA | 27.7 | 21.5 | 18.5 – 27.7 | Middle |
| Price/book | 31.2 | 5.71 | 3.51 – 19.1 | High |
| Price/sales | 6.44 | 6.20 | 2.45 – 7.36 | Middle |
| Gross margin | 72.2% | 55.9% | 33.1% – 65.2% | High |
| Operating margin | 21.4% | 14.3% | 6.9% – 17.7% | High |
| Net margin | 18.2% | 8.1% | 3.1% – 13.9% | High |
| ROE | 117.9% | 13.4% | 3.8% – 29.6% | High |
| Debt/equity | 0.29 | 0.74 | 0.34 – 0.83 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Medpace Holdings: valuation over time
On the latest fiscal year's earnings (2025), Medpace Holdings's P/E today is 42.3, above the median of its last 10 fiscal years (35.4; between 26.3 and 97.5 from 2016 to 2025). Relative to earnings, the stock costs more than it used to.
| Fiscal year | Price at year end | Earnings per share | P/E |
|---|---|---|---|
| 2025 | $561.65 | $15.28 | 36.8 |
| 2024 | $332.23 | $12.63 | 26.3 |
| 2023 | $306.53 | $8.88 | 34.5 |
| 2022 | $212.41 | $7.28 | 29.2 |
| 2021 | $217.64 | $4.81 | 45.2 |
| 2020 | $139.20 | $3.84 | 36.2 |
| 2019 | $84.06 | $2.67 | 31.5 |
| 2018 | $52.93 | $1.97 | 26.9 |
| 2017 | $36.26 | $0.98 | 37.0 |
| 2016 | $36.07 | $0.37 | 97.5 |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $18.27B
- Enterprise value
- $17.6B
- PEG
- 3.33
- EV/revenue
- 6.20
Profitability and growth
- ROA
- 18.7%
- ROIC
- 63.6%
- Revenue growth (year over year)
- 8.5%
- Earnings growth (year over year)
- 25.4%
Financial health
- Total cash
- $705.32M
- Total debt
- $171.46M
- Current ratio
- 0.83
- Quick ratio
- 0.77
- Altman Z-Score
- 7.00
- Piotroski F-Score
- 7.00
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $651.31
- Median price target
- $675.00
- High price target
- $730.00
- Low price target
- $370.00
- Analysts with a price target
- 13
- Forward EPS
- $19.85
- EPS estimate, current year
- $18.36
Shares and trading
- Beta
- 1.11
- Average volume
- 257.56K
- Shares outstanding
- 27.97M
- Float
- 22.73M
- Institutional ownership
- 85.3%
- Insider ownership
- 18.7%
- Short interest (% of float)
- 6.2%
- Short ratio (days)
- 4.24
